(Q41439181)

30 September 2017

The effect of human myelomonocytic leukemic cell line (M20) derived IL-1 inhibitor on human erythroid cell development (English)

1 reference

30 September 2017

1 reference

Fibach E

1

1 reference

30 September 2017

Rigel M

2

1 reference

30 September 2017

Peled T

3

1 reference

30 September 2017

Treves AJ

4

1 reference

30 September 2017

Barak V

5

1 reference

30 September 2017

1 October 1994

1 reference

30 September 2017

1 reference

30 September 2017

15

1 reference

30 September 2017

3-4

1 reference

30 September 2017

327-332

1 reference

The M20 IL-1 inhibitor. I. Purification by preparative isoelectric focusing in free solution

30 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

The M20 IL-1 inhibitor. II. Biological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

The M20 IL-1 inhibitor prevents onset of adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Differentiation in erythroleukemic cells and their somatic hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Interleukin-1: biological effects in human hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Role of interleukin-1 in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Native interleukin 1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

In vivo anti inflammatory effects of the M20 IL-1 inhibitor: I. Effects on acute inflammatory parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

In vivo anti-inflammatory effects of the M20 IL-1 inhibitor: II. Effects on serum reactants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199409049731

10.3109/10428199409049731

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference